Literature DB >> 9060023

Pain characteristics help to predict the analgesic efficacy of radiotherapy for the treatment of cancer pain.

E H Rutten1, B J Crul, P P van der Toorn, A W Otten, R Dirksen.   

Abstract

It is recognised that radiotherapy provides relief for intractable pain in approximately 50% of patients with cancer pain. Unfortunately, traditional explanatory variables, such as age, gender, histology or radiation dose, do not help to predict which individuals will benefit from palliative radiotherapy. A non-randomised prospective clinical trial was conducted on 51 patients to evaluate the value of pain characteristics as new explanatory variables for predicting the efficacy of palliative radiotherapy for providing cancer pain relief. Two new explanatory variables were identified: the presence of radiating pain and the pain score before radiotherapy.

Entities:  

Mesh:

Year:  1997        PMID: 9060023     DOI: 10.1016/s0304-3959(96)03253-8

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  3 in total

1.  Influence of pain duration on pain outcomes following palliative radiotherapy for painful tumors: the sooner the irradiation, the better?

Authors:  Tetsuo Saito; Kenta Murotani; Kohsei Yamaguchi; Ryo Toya; Etsushi Tomitaka; Takahiro Watakabe; Natsuo Oya
Journal:  Strahlenther Onkol       Date:  2021-03-30       Impact factor: 3.621

2.  Inconsistencies in assessment of pain endpoints in radiotherapy for painful tumors: Analysis of original articles in the Green and Red Journals.

Authors:  Tetsuo Saito; Naoto Shikama; Atsunori Yorozu; Hikaru Kubota; Kenta Murotani; Kohsei Yamaguchi; Natsuo Oya; Naoki Nakamura
Journal:  Clin Transl Radiat Oncol       Date:  2020-07-24

3.  Continued success of the rapid response radiotherapy program: a review of 2004-2008.

Authors:  Eric de Sa; Emily Sinclair; Gunita Mitera; Jennifer Wong; Cyril Danjoux; Amanda Hird; Stephanie Hadi; Elizabeth Barnes; May Tsao; Edward Chow
Journal:  Support Care Cancer       Date:  2009-01-30       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.